@PureCommTwitter Feed follow us on Twitter
Dicerna Closes $25 Million Series B Financing
Trevena Secures $35 Million in Series B Funding to Progress Portfolio of GPCR Biased Ligands and to Complete Phase 2 Study of TRV120027 for Acute Heart Failure
Infinity and Intellikine Enter Agreement to Develop Oral Therapies Targeting PI3 Kinase Delta, Gamma
Lilly to Acquire Alnara Pharmaceuticals: Alnara's Pancreatic Enzyme Replacement Therapy, Liprotamase, Currently Under FDA Review
AVEO Pharmaceuticals to Close NASDAQ Stock Market on June 22, 2010
Ablexis Appoints R. Scott Greer Chairman of the Board and Richard Hoffman Chief Business Officer
VBL Therapeutics Presents Positive Preclinical Data on Immune Modulator in Rheumatoid Arthritis at EULAR Annual Meeting
Predictive Biosciences Closes $25 Million Series C Financing
NEXT
